Related Experiment Videos
Cytotoxic flavonoids with isoprenoid groups from Morus mongolica
1Faculty of Pharmaceutical Sciences, Toho University, 2-2-1 Miyama, Funabashi, Chiba 274-8510, Japan.
Journal of Natural Products
|June 30, 2001
Summary
Researchers discovered new compounds from Morus mongolica, including a pyranoflavanone and 2-arylbenzofurans. Flavanones showed potent cytotoxicity against oral tumor cells, with sanggenol M being most effective.
Area of Science:
- Natural Product Chemistry
- Medicinal Chemistry
- Pharmacology
Background:
- Morus mongolica is a traditional medicinal plant with diverse bioactive compounds.
- Flavonoids and benzofurans are classes of natural products known for their biological activities.
- Cytotoxicity and tumor specificity are key parameters in evaluating potential anti-cancer agents.
Purpose of the Study:
- To isolate and characterize novel compounds from Chinese Morus mongolica.
- To evaluate the cytotoxic effects of isolated compounds against human oral tumor cell lines.
- To compare the cytotoxicity and tumor specificity of different compound classes.
Main Methods:
- Isolation of compounds using chromatographic techniques.
- Structure elucidation of novel compounds via spectroscopic methods (NMR, MS).
- In vitro cytotoxicity assays against oral tumor cell lines (HSC-2, HSG) and normal fibroblasts (HGF).
Main Results:
- A new pyranoflavanone (sanggenol L) and four new 2-arylbenzofurans (mulberrofurans W-Z) were identified.
- Ten known flavonoids were also isolated from the plant extract.
- Flavanones, including sanggenol M, exhibited significant cytotoxicity against oral tumor cells, with higher potency than 2-arylbenzofurans.
- Compound 2 and sanggenon C demonstrated the most potent cytotoxicity.
Conclusions:
- Morus mongolica is a rich source of bioactive flavonoids and benzofurans.
- The isolated flavanones possess promising cytotoxic activity against oral cancer cell lines.
- Further investigation into sanggenol M and sanggenon C may lead to novel anti-cancer therapeutics.